R&D Strategies in securing funding for rare disease research An outline of emerging financing strategies for rare disease research in challenging times.
R&D JP Morgan 2023 - Astrocyte Pharmaceuticals pharmaphorum spoke with Astrocyte's Kevin Sheth, William Korinek, and James D. Lechleiter
R&D Advanced manufacturing to pave way for pharma industry The time for transition to sustainable strategies is now.
R&D A look back at RNA Therapeutics – day one The 14th Annual RNA Therapeutics Conference took place in Kensington, London this year.
R&D JP Morgan 2023 - Stefan Weber and Ravi Anand pharmaphorum sits down with Stefan Weber and Ravi Anand of neurology-focused biotech Newron.
Sales & Marketing Sponsored Investing in healthcare futures: Elia Stupka and Paul Tunnah Angelini Ventures is an new investment fund seeking companies transformational in healthcare.
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
